Summary
We developed antisera and radioimmunoassays against synthetic replicas of glucagon-like peptide-1 (1–36) and -2, predicted products of the glucagon precursor, and against glucagon-like peptide-1 (7–36) identical to the sequence of glucagon-like peptide-1, but lacking its first six N-terminal amino acids. With these tools, we studied the localisation and molecular nature of glucagon-like immunoreactivity in human pancreas, small intestine and plasma. By immunohistochemistry glucagon-like peptide-1, and glucagon-like peptide-2 immunoreactivity coexisted with glucagon in pancreatic islet cells and with enteroglucagon in small intestinal enteroglucagon-producing cells. By chromatography of tissue extracts we found that glucagon-like peptide-1 and glucagon-like peptide-2-immunoreactivities in the human pancreas (307±51 and 107±37 pmol/g tissue) were mainly contained in a large peptide, whereas in the small intestine glucagon-like peptide-1 and glucagon-like peptide-2 immunoreactivities were found in separate smaller molecules (49±21 and 77±28/g tissue). By isocratic high pressure liquid chromatography of the large pancreatic glucagon-like peptide we found that this peptide is heterogeneous. By chromatographic analysis glucagon-like peptide-1 immunoreactivity in fasting plasma was mainly found in a large peptide corresponding to the pancreatic form, while after a meal a smaller molecular form coeluting by gel filtration with glucagon-like peptide-1 predominated.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC (1983) Exon duplication and divergence in the human preproglucagon gene. Nature 304: 369–371
Heinrich G, Gros P, Habener JF (1984) Glucagon gene sequence four of six exons encode separate functional domains of rat preproglucagon. J Biol Chem 259: 14082–14088
Holst JJ, Ørskov C, Schwartz TW (1987) Truncated glucagonlike peptide-1, an insulin-releasing peptide from the distal gut. FEBS Lett 221: 169–174
Ørskov C, Holst JJ (1987) Radioimmunoassays for Glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). Scand J Clin Lab Invest 47: 165–174
Schaffalitzky de Muckadell OB, Fahrenkrug J (1976) Preparation of 125I-labelled synthetic porcine secretin for radioimmunoassay. Scand J Clin Lab Invest 36: 661–668
Holst JJ (1982) Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33–69) of glicentin. Biochem J 207: 381–388
Holst JJ (1983) Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin-current status. Gastroenterol 84: 1602–1613
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–669
Holst JJ, Aasted B (1974) Production and evaluation of glucagon antibodies for radioimmunoassay. Acta Endocrinol (Copenh) 77: 715–724
Newgard CB, Holst JJ (1981) Heterogeneity of somatostatin like immunoreactivity in extracts of porcine, canine and human pancreas. Acta Endocrinol (Copenh) 89: 564–572
Holst JJ, Pedersen JH, Baldissera FGA, Stadil F (1983) Circulating glucagon after total pancreatectomy in man. Diabetologia 25: 396–399
Sternberger L (1974) Immunohistochemistry. Prentice Hall, Englewood Cliffs, NJ, pp 129–171
Baldissera FGA, Holst JJ (1984) Glucagon-related peptides in the human gastrointestinal mucosa. Diabetologia 26: 223–228
Varndell IM, Bishop AE, Sikri KL, Uttenthal LO, Bloom SR, Polak JM (1985) Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J Histochem Cytochem 33: 1080–1086
Ørskov C, Holst JJ, Knuhtsen S, Baldissera FGA, Seier Poulsen S, Nielsen OV (1986) Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinol 119: 1467–1475
Patzelt C, Schiltz E (1984) Conversion of proglucagon in pancreatic alpha cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences. Proc Natl Acad Sci (USA) 81: 5007–5011
Uttenthal LO, Ghiglione M, George SK, Bishop AE, Polak JM, Bloom SR (1985) Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas. J Clin Endocrinol Metab 61: 472–479
George SK, Uttenthal LO, Ghiglione M, Bloom SR (1985) Molecular forms of glucagon-like peptides in man. Febs Lett 192: 275–278
Buhl T, Baldissera FGA, Holst JJ, Kofod J, Nielsen OV, Thim L, Ørskov C (1987) Glucagon-like peptide 2 (GLP-2) in the porcine and human intestinal mucosa. J Physiol 390: 254P (Abstract)
Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF (1986) Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem: 11880–11889
Ghiglione M, Uttenthal LO, George SK, Bloom SR (1984) How glucagon-like is glucagon-like peptide 1? Diabetologia 27: 599–600
Schmidt WE, Siegel EG, Creutzfeldt W (1985) Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28: 704–707
Mojsov S, Weir GC, Habener JF (1987) Insulinotropin: Glucagonlike peptide 1 (7–37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79: 616–619
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ørskov, C., Holst, J.J., Poulsen, S.S. et al. Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30, 874–881 (1987). https://doi.org/10.1007/BF00274797
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00274797